Transdermal drug delivery system: An overview

International Journal of Pharmaceutical Sciences Review and Research

Volumn 3, Issue 2, 2010, Pages 49-54

  Kumar, J Ashok ^a   Pullakandam, Nikhila ^a   Prabu, S Lakshmana ^b   Gopal, V ^c  

^a PRIST UNIVERSITY   (India)

^b ANNA UNIVERSITY   (India)

^c Mother Theresa Post Graduate and Research Institute of Health Sciences   (India)

Author keywords

Systemic blood circulation; TDDS; Topical drug delivery

Indexed keywords

DRUG CARRIER; ETHYLENE VINYL ACETATE COPOLYMER; LIPOSOME; MERCURY; POLY(4 METHYL 1 PENTENE); POLYETHYLENE; POLYMER; UNCLASSIFIED DRUG;

ARTICLE; CIRCULATION; DRUG IN ADHESIVE SYSTEM; DRUG METABOLISM; DRUG RELEASE; DRUG STABILITY; DRUG TRANSPORT; HYDROPHILICITY; LIPOPHILICITY; MATRIX DISPERSION SYSTEM; MEMBRANE PERMEABILITY; MICRORESERVOIR SYSTEM; PHYSICAL CHEMISTRY; RESERVOIR; THERMODYNAMICS; TRANSDERMAL DRUG ADMINISTRATION; TRANSDERMAL PATCH; WATER VAPOR;

EID: 79952028612     PISSN: None     EISSN: 0976044X     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. st Ed., CBS Publishers and distributors, New Delhi, 2001 pp.108-110.
2. th Edition., Wolter Kluwer Publishers,New Delhi, 2005 pp. 298-299.
3. Chein Y.W. Transdermal drug delivery and delivery system. In, Novel drug delivery system, Vol. 50, Marcel Dekker, Inc., New york, 1992 pp.301-381.
4. Willams A.C and barry B. W., "Penetration Enhancers," Adv. Drug Del.Rev.2004;56: 603-618.
5. Pellet M, Raghavan S.L, Hadgraft J and DavisA.F. "The application of supersaturated systems to percutaneous drug delivery" In: Guy R.H and Hadgraft J. Transdermal drug delivery, Marcel Dekker, Inc., New york 2003pp. 305-326.
6. Brown M.B and Jones S.A. Hyaluronic acid: a unique topical vehicle for localized drug delivery of drugs to the skin. JEDV 2000;19:308-318.
7. Tsai J.C, Guy R.H, Thornfeldt C.R, GaoW.N, Feingold K.R and Elias P.M. "Metabolic Approaches to Enchance Transdermal drug delivery". Jour. pharm. Sci., 1998; 85:643-648.
8. Berner B and John V.A. Pharmacokinetic characterization of Transdermal delivery systems. Jour.Clinical pharmacokinetics 1994; 26 (2): 121-34.
9. Baker W and Heller J. "Material Selection for Transdermal Delivery Systems", In Transdermal Drug Delivery: Developmental Issues and Research Initiatives, J.Hadgraft and R.H.Guys, Eds. Marcel Dekker, Inc.,New york 1989 pp. 293-311.
10. Wiechers J. Use of chemical penetration enhancers in Transdermal drug delivery-possibilities and difficulties. Acta pharm. 1992: 4: 123.
11. Yamamoto T, Katakabe k, Akiyoshi K, Kan K and Asano T. Topical application of glibenclamide lowers blood glucose levels in rats. Diabetes res. Clin. Pract. 1990; 8: 19-22.
12. Al- Khamis K, Davis S.S and Hadgraft J. Microviscosity and drug release from topical gel formulations. Pharm. Res. 1986; 3: 214-217.
13. Anon. Transdermal delivery systems-general drug release standards. Pharmacopeial Forum, 1980; 14: 3860-3865.
14. Mayorga P, Puisieux F and Couarraze G. Formulation study of a Transdermal delivery system of primaquine. Int. J. pharm. 1996; 132: 71-79.
15. Deo M.R, Sant V.P,Parekh S.R, Khopade A.J and Banakar U.V. Proliposome-based Transdermal delivery of levonorgestrel. Jour. Biomat. Appl. 1997; 12: 77-88.
16. Yan-yu X, Yun- mei S, Zhi-Peng C and Qi-nerg P. Preparation of silymarin proliposomes; A new way to increase oral bioavailability of silymarin in beagle dogs. Int. pharm. 2006; 319: 162-168.
17. Crawford R.R and Esmerian O.K. Effect of plasticizers on some physical properties of cellulose acetate phthalate films. J. Pharm. Sci. 1997;60: 312-314.
18. Singh J, Tripathi K.T and SakiaT.R. Effect of penetration enhancers on the invitro transport of ephedrine through rate skin and human epidermis from matrix based Transdermal formulations. Drug Dev.Ind. Pharm. 1993; 19: 1623-1628.
19. Wade A, Weller P.J. Handbook of pharmaceutical Excipients. Washington, DC: American Pharmaceutical Publishing Association; 1994: 362-366.
20. Rhaghuram reddy k, Muttalik S and Reddy S. Once - daily sustained- release matrix tablets of nicorandil: formulation and invitro evaluation. AAPS Pharm.Sci.Tech. 2003;4:4.
21. Shaila L, Pandey S and Udupa N. Design and evaluation of matrix type membrane controlled Transdermal drug delivery system of nicotin suitable for use in smoking cessation. Indian Journ. Pharm. Sci. 2006;68: 179-184
22. Aarti N, Louk A.R.M.P, Russsel.O.P and Richard H.G. Mechanism of oleic acid induced skin permeation enhancement in vivo in humans. Jour. control. Release 1995; 37: 299-306.
23. Wade A and Weller P.J. Handbook of pharmaceutical Excipients. Washington, DC: American Pharmaceutical Publishing Association 1994; 362-366.
24. Lec S.T, Yac S.H, Kim S.W and Berner B. One way membrane for Transdermal drug delivery systems / system optimization. Int. J Pharm. 1991; 77: 231-237.
25. st Ed., CBS Publishers and distributors, New Delhi, 2002; 411-447.